Combined with the above studies, we hypothesize that elevated concentrations of ADAM8 may enhance Th2 immune responses and eosinophil recruitment in polyp tissue, exacerbating eosinophilic inflammation and increasing the risk of adverse prognosis and recurrence. The gene discussed is ADAM8; the disease is polyp.